HER-2, a member of the EGFR family whose amplification is present in about 25% of human breast cancers, correlates with a distinct molecular profile and unfavorable outcome and has been shown to regulate the mammary stem/progenitor cell population driving tumorigenesis and invasion [25]. This evidence concerns the gene ERBB2 and breast carcinoma.